about
eNanoMapper: harnessing ontologies to enable data integration for nanomaterial risk assessmentPerspectives on next steps in classification of oro-facial pain - part 2: role of psychosocial factorsCommunity-based Ontology Development, Annotation and Discussion with MediaWiki extension Ontokiwi and Ontokiwi-based OntobediaAn effective method of large scale ontology matchingOntology-based collection, representation and analysis of drug-associated neuropathy adverse eventsAnalysis of Individual Differences in Vaccine Pharmacovigilance Using VAERS Data and MedDRA System Organ Classes: A Use Case Study With Trivalent Influenza Vaccine.The potential of translational bioinformatics approaches for pharmacology research.Differential Adverse Event Profiles Associated with BCG as a Preventive Tuberculosis Vaccine or Therapeutic Bladder Cancer Vaccine Identified by Comparative Ontology-Based VAERS and Literature Meta-AnalysisLinking MedDRA(®)-Coded Clinical Phenotypes to Biological Mechanisms by the Ontology of Adverse Events: A Pilot Study on Tyrosine Kinase Inhibitors.Ontology-based Vaccine and Drug Adverse Event Representation and Theory-guided Systematic Causal Network Analysis toward Integrative Pharmacovigilance ResearchStatistical and Ontological Analysis of Adverse Events Associated with Monovalent and Combination Vaccines against Hepatitis A and B Diseases.Therapeutic indications and other use-case-driven updates in the drug ontology: anti-malarials, anti-hypertensives, opioid analgesics, and a large term request.Use of Biomedical Ontologies for Integration of Biological Knowledge for Learning and Prediction of Adverse Drug Reactions.A bioinformatics roadmap for the human vaccines project.The anatomy of phenotype ontologies: principles, properties and applications.MedDRA® automated term groupings using OntoADR: evaluation with upper gastrointestinal bleedings.Ontology-based specification, identification and analysis of perioperative risks.Vaccine and Drug Ontology Studies (VDOS 2014).Evaluating Casama: Contextualized semantic maps for summarization of lung cancer studies.Ontology-based systematical representation and drug class effect analysis of package insert-reported adverse events associated with cardiovascular drugs used in China.Drug knowledge bases and their applications in biomedical informatics research.Ontology-Based Vaccine Adverse Event Representation and Analysis.The eXtensible ontology development (XOD) principles and tool implementation to support ontology interoperability.Ontology-based systematic representation and analysis of traditional Chinese drugs against rheumatism.Ontology-Based Meta-Analysis of Animal and Human Adverse Events Associated With Licensed Brucellosis Vaccines.Towards precision informatics of pharmacovigilance: OAE-CTCAE mapping and OAE-based representation and analysis of adverse events in patients treated with cancer drugs.Ontology-based literature mining and class effect analysis of adverse drug reactions associated with neuropathy-inducing drugs.OpenPVSignal: Advancing Information Search, Sharing and Reuse on Pharmacovigilance Signals via FAIR Principles and Semantic Web Technologies.
P2860
Q27062683-DB9C9071-B78E-4FF7-992D-0E57E23AC6A0Q28085732-1F25AA7B-475A-44AF-B37F-FAAE35A886CFQ28596944-522A4841-876F-4632-B1E1-46B2963DD9C1Q28652011-17066609-5DD7-4EBF-ACF2-7D4E76C6E649Q28833683-B2251C84-4929-4A48-B11A-11ECD92D7C1DQ33563415-95BB085C-23E0-46C3-9EBF-54755E649C30Q36125546-57265A9E-DC15-4554-A84B-C3E320AC1026Q36165332-69546A5C-3D76-4D06-AC1D-27732F6DF504Q37066174-F6CD15A3-7B82-4F72-8E51-D6FC610BC291Q37118671-7C0D23C3-4B8A-418A-9BD6-717FCC08FC07Q37303528-6E969F88-1426-431F-A604-F5A0ABC9D904Q37679155-2DBA5F9C-83EA-4AAB-B403-3C3A9FC63EDEQ38370993-8F61F03A-5DF0-40F1-A963-127EB7AB724AQ38371212-64045076-94F9-4DE5-8985-31E6E19D004FQ38378393-2CE0B7F8-6904-43D4-9915-15ED42DDAC02Q38390830-C3BEE593-D207-4664-B010-2FDB2220B79EQ40055425-6A3D89FE-6533-4957-B98C-3F44559E2709Q42590658-5ABF1187-CD90-4E94-A10F-042D7D49AB86Q45992660-FE472C72-2300-4A41-8145-5DEF4038BFBFQ47147374-8F6D86CE-2F74-4B14-93EA-0AE5774B5575Q47205411-87C5ABD0-F9A2-46F8-9207-5FDA5243D80AQ47236978-430FAAAE-0449-49D9-A517-E75C7CBF7065Q48252153-AA2AC086-CBBC-484C-8385-721BB31CD51FQ48503272-9A441642-4AD5-4FDA-9409-4D5C5E16A516Q55131172-051FE368-C205-4CCC-BA7C-4257CE87913EQ55361610-84DA150E-72A9-4E22-962A-83297F77C6E3Q55455428-D5808A25-B4BA-4DD5-BE2D-D63342117019Q55709260-740D87BB-8FFE-430C-A99E-7EEEDA94C87E
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
OAE: The Ontology of Adverse Events.
@ast
OAE: The Ontology of Adverse Events.
@en
type
label
OAE: The Ontology of Adverse Events.
@ast
OAE: The Ontology of Adverse Events.
@en
prefLabel
OAE: The Ontology of Adverse Events.
@ast
OAE: The Ontology of Adverse Events.
@en
P2093
P2860
P50
P356
P1476
OAE: The Ontology of Adverse Events.
@en
P2093
Desikan Jagannathan
Luca Toldo
Shelley Zhang
Zuoshuang Xiang
P2860
P2888
P356
10.1186/2041-1480-5-29
P577
2014-07-05T00:00:00Z
P5875
P6179
1030736387